Untangling the Infection-Immune-Brain Connection and Case Studies Using the Autoimmune Brain Panel™

Описание: Professor Craig Shimasaki explores the complex interplay between infections, immune responses, and neuropsychiatric symptoms.

He delves into how infections such as streptococcus, Lyme disease, mycoplasma, and others can trigger autoimmune reactions that target the brain, often resulting in symptoms such as OCD, anxiety, ADHD, depression, and behavioural disturbances.

Drawing on both the latest research and clinical experience, he explains the mechanism of molecular mimicry, discuss immune biomarkers, and present real-world case studies using the Autoimmune Brain Panel™ (formerly Cunningham Panel).

This session provides valuable insights for clinicians and researchers interested in infection-triggered neuroimmune conditions such as PANS/PANDAS, Sydenham’s chorea, and post-infectious neuropsychiatric syndromes.

Join us for an in-depth look at diagnostic tools, interpretation of results, and treatment strategies that are changing lives.

ABOUT THE SPEAKER

Professor Craig Shimasaki, PhD, MBA President & CEO Moleculera Biosciences, Inc.

Professor Shimasaki received his BS in Biochemistry from the University of California at Davis, his PhD in Molecular Biology and Biotechnology from the University of Tulsa, and his MBA from Northwestern University, Kellogg School of Business.

He is an Adjunct Professor at the University of Oklahoma and is the cofounder and CEO of Moleculera Biosciences, a neuroimmunology precision medicine company focused on identifying and treating the underlying roots of neurologic, psychiatric, and behavioral disorders triggered by an autoimmune response.

He has spent over 35 years working in the fields of molecular biology, viral pathogenesis, and infection-triggered autoimmune neuropsychiatric disorders.

Prof. Shimasaki started his career at Genentech and has worked across all stages of research, development, clinical trials, and regulatory approval of technology innovation from bench-to-bedside. His research work includes epitope mapping of HIV proteins, genetic-based predictors of breast cancer risk, influenza and RSV diagnostics and therapeutics, and the pathogenesis of infection-triggered neuropsychiatric disorders.

He has co-founded multiple companies and led multiple products through the FDA approval process and is a co-inventor on multiple patents. Internationally, he teaches and mentors scientists, physicians and biotech leaders on how to translate their research into acutely needed medical interventions. His passion is to translate scientific discoveries into acutely needed products so that more patients can live longer, healthier lives.